Showing results (71-80 of 361) with videos related to
Sort By:
Pageof 37
Journal of Diabetes Science and Technology|July 12, 2014
Using the glucometrics website to benchmark ICU glucose control before and after the NICE-SUGAR studyRanee R Lleva, Prem Thomas, Janis E Bozzo, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2010
Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitusAther Ali, Yingying Ma, Jesse Reynolds, et al.Joint Commission Journal on Quality and Patient Safety|September 26, 2012
Discontinuation of antihyperglycemic therapy after acute myocardial infarction: medical necessity or medical error?Kay O Lovig, Leora Horwitz, Kasia Lipska, et al.International Journal of Stroke : Official Journal of the International Stroke Society|December 4, 2018
Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular diseaseJennifer L Dearborn, Catherine M Viscoli, Silvio E Inzucchi, et al.Diabetes Care|August 21, 2010
Initial combination therapy with alogliptin and pioglitazone in drug-naïve patients with type 2 diabetesJulio Rosenstock, Silvio E Inzucchi, Jochen Seufert, et al.Annals of Internal Medicine|April 20, 2011
Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trialsFaramarz Ismail-Beigi, Etie Moghissi, Margaret Tiktin, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 6, 2011
Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocolShilpa Shetty, Silvio E Inzucchi, Philip A Goldberg, et al.Diabetes, Obesity & Metabolism|January 29, 2019
FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade laterDarren K McGuire, Nikolaus Marx, Odd Erik Johansen, et al.Diabetes, Obesity & Metabolism|September 24, 2021
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trialJoão Pedro Ferreira, Silvio E Inzucchi, Michaela Mattheus, et al.Journal of Pharmaceutical Policy and Practice|April 16, 2021
Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefitsDarren K McGuire, Silvio E Inzucchi, Odd Erik Johansen, et al.Pageof 37